Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.

Article PubMed Google Scholar

Doudna JA. The promise and challenge of therapeutic genome editing. Nature. 2020;578(7794):22936.

Article CAS PubMed PubMed Central Google Scholar

Nambiar TS, Baudrier L, Billon P, Ciccia A. CRISPR-based genome editing through the lens of DNA repair. Mol Cell. 2022;82(2):34888.

Article CAS PubMed PubMed Central Google Scholar

Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):126278.

Article CAS PubMed PubMed Central Google Scholar

Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell. 2017;169(3):559.

Article CAS PubMed Google Scholar

Knott GJ, Doudna JA. CRISPR-Cas guides the future of genetic engineering. Science. 2018;361(6405):8669.

Article CAS PubMed PubMed Central Google Scholar

Li G, Li X, Zhuang S, Wang L, Zhu Y, Chen Y, et al. Gene editing and its applications in biomedicine. Sci China Life Sci. 2022;65(4):660700.

Article CAS PubMed PubMed Central Google Scholar

Yang X. Applications of CRISPR-Cas9 mediated genome engineering. Mil Med Res. 2015;2:11.

PubMed PubMed Central Google Scholar

Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):81923.

Article CAS PubMed PubMed Central Google Scholar

Liu G, Lin Q, Jin S, Gao C. The CRISPR-Cas toolbox and gene editing technologies. Mol Cell. 2022;82(2):33347.

Article CAS PubMed Google Scholar

Pickar-Oliver A, Gersbach CA. The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019;20(8):490507.

Article CAS PubMed PubMed Central Google Scholar

Porteus MH. A new class of medicines through DNA editing. N Engl J Med. 2019;380(10):94759.

Article CAS PubMed Google Scholar

Yeh CD, Richardson CD, Corn JE. Advances in genome editing through control of DNA repair pathways. Nat Cell Biol. 2019;21(12):146878.

Article CAS PubMed Google Scholar

Clark JF, Dinsmore CJ, Soriano P. A most formidable arsenal: genetic technologies for building a better mouse. Genes Dev. 2020;34(1920):125686.

Article CAS PubMed PubMed Central Google Scholar

Nishiga M, Liu C, Qi LS, Wu JC. The use of new CRISPR tools in cardiovascular research and medicine. Nat Rev Cardiol. 2022;19(8):50521.

Article CAS PubMed Google Scholar

Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533(7603):4204.

Article CAS PubMed PubMed Central Google Scholar

Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of AT to GC in genomic DNA without DNA cleavage. Nature. 2017;551(7681):46471.

Article CAS PubMed PubMed Central Google Scholar

Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576(7785):14957.

Article CAS PubMed PubMed Central Google Scholar

Watkins WS, Hernandez EJ, Wesolowski S, Bisgrove BW, Sunderland RT, Lin E, et al. De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapes. Nat Commun. 2019;10(1):4722.

Article PubMed PubMed Central Google Scholar

Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, Depalma SR, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49(11):1593601.

Article CAS PubMed PubMed Central Google Scholar

Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13(11):72236.

Article CAS PubMed PubMed Central Google Scholar

Dolan AE, Hou Z, Xiao Y, Gramelspacher MJ, Heo J, Howden SE, et al. Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using type I CRISPR-Cas. Mol Cell. 2019;74(5):936-50.e5.

Article CAS PubMed PubMed Central Google Scholar

Morisaka H, Yoshimi K, Okuzaki Y, Gee P, Kunihiro Y, Sonpho E, et al. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells. Nat Commun. 2019;10(1):5302.

Article CAS PubMed PubMed Central Google Scholar

Osakabe K, Wada N, Murakami E, Miyashita N, Osakabe Y. Genome editing in mammalian cells using the CRISPR type I-D nuclease. Nucleic Acids Res. 2021;49(11):634763.

Article CAS PubMed PubMed Central Google Scholar

Tan R, Krueger RK, Gramelspacher MJ, Zhou X, Xiao Y, Ke A, et al. Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems. Mol Cell. 2022;82(4):852-67.e5.

Article CAS PubMed PubMed Central Google Scholar

Liu TY, Doudna JA. Chemistry of class 1 CRISPR-Cas effectors: binding, editing, and regulation. J Biol Chem. 2020;295(42):1447387.

Article CAS PubMed PubMed Central Google Scholar

Altae-Tran H, Kannan S, Demircioglu FE, Oshiro R, Nety SP, Mckay LJ, et al. The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases. Science. 2021;374(6563):5765.

Article CAS PubMed PubMed Central Google Scholar

Karvelis T, Druteika G, Bigelyte G, Budre K, Zedaveinyte R, Silanskas A, et al. Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. Nature. 2021;599(7886):6926.

Article CAS PubMed PubMed Central Google Scholar

Schuler G, Hu C, Ke A. Structural basis for RNA-guided DNA cleavage by IscB-RNA and mechanistic comparison with Cas9. Science. 2022;376(6600):147681.

Article CAS PubMed Google Scholar

Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature. 2015;520(7546):18691.

Article CAS PubMed PubMed Central Google Scholar

Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A. 2013;110(39):156449.

Article CAS PubMed PubMed Central Google Scholar

Kim E, Koo T, Park SW, Kim D, Kim K, Cho HY, et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat Commun. 2017;8:14500.

Article CAS PubMed PubMed Central Google Scholar

Edraki A, Mir A, Ibraheim R, Gainetdinov I, Yoon Y, Song CQ, et al. A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing. Mol Cell. 2019;73(4):714-26 e4.

Article CAS PubMed Google Scholar

Liu JJ, Orlova N, Oakes BL, Ma E, Spinner HB, Baney KLM, et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature. 2019;566(7743):21823.

Article CAS PubMed PubMed Central Google Scholar

Kim DY, Lee JM, Moon SB, Chin HJ, Park S, Lim Y, et al. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nat Biotechnol. 2022;40(1):94102.

Article CAS PubMed Google Scholar

Wu Z, Zhang Y, Yu H, Pan D, Wang Y, Wang Y, et al. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat Chem Biol. 2021;17(11):11328.

Article CAS PubMed Google Scholar

Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol Cell. 2021;81(20):4333-45.e4

Article CAS PubMed Google Scholar

Pausch P, Al-Shayeb B, Bisom-Rapp E, Tsuchida CA, Li Z, Cress BF, et al. CRISPR-Cas from huge phages is a hypercompact genome editor. Science. 2020;369(6501):3337.

Article CAS PubMed PubMed Central Google Scholar

Al-Shayeb B, Skopintsev P, Soczek KM, Stahl EC, Li Z, Groover E, et al. Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors. Cell. 2022;185(24):4574-86.e16.

Article CAS PubMed Google Scholar

Collias D, Beisel CL. CRISPR technologies and the search for the PAM-free nuclease. Nat Commun. 2021;12(1):555.

Article CAS PubMed PubMed Central Google Scholar

Miller SM, Wang T, Randolph PB, Arbab M, Shen MW, Huang TP, et al. Continuous evolution of SpCas9 variants compatible with non-G PAMs. Nat Biotechnol. 2020;38(4):47181.

Article CAS PubMed PubMed Central Google Scholar

Walton RT, Christie KA, Whittaker MN, Kleinstiver BP. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science. 2020;368(6488):2906.

Article CAS PubMed PubMed Central Google Scholar

Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2019;37(3):27682.

Article CAS PubMed PubMed Central Google Scholar

Tth E, Varga , Kulcsr PI, Kocsis-Jutka V, Krausz SL, Nyeste A, et al. Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases. Nucleic Acids Res. 2020;48(7):372233.

Article PubMed PubMed Central Google Scholar

Chatterjee P, Jakimo N, Lee J, Amrani N, Rodriguez T, Koseki SRT, et al. An engineered ScCas9 with broad PAM range and high specificity and activity. Nat Biotechnol. 2020;38(10):11548.

Article CAS PubMed Google Scholar

Chatterjee P, Lee J, Nip L, Koseki SRT, Tysinger E, Sontheimer EJ, et al. A Cas9 with PAM recognition for adenine dinucleotides. Nat Commun. 2020;11(1):2474.

Article CAS PubMed PubMed Central Google Scholar

Ma D, Xu Z, Zhang Z, Chen X, Zeng X, Zhang Y, et al. Engineer chimeric Cas9 to expand PAM recognition based on evolutionary information. Nat Commun. 2019;10(1):560.

Article CAS PubMed PubMed Central Google Scholar

Liu RM, Liang LL, Freed E, Chang H, Oh E, Liu ZY, et al. Synthetic chimeric nucleases function for efficient genome editing. Nat Commun. 2019;10(1):5524.

Article CAS PubMed PubMed Central Google Scholar

Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science. 2016;351(6268):848.

Article CAS PubMed Google Scholar

Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature. 2016;529(7587):4905.

Article CAS PubMed PubMed Central Google Scholar

Read more:
Recent advances in CRISPR-based genome editing technology and ... - Military Medical Research